Literature DB >> 2404525

Homozygous deletion of the retinoblastoma gene in an acute lymphoblastic leukemia (T) cell line.

J Cheng1, P Scully, J Y Shew, W H Lee, V Vila, M Haas.   

Abstract

Human leukemia cell lines were examined for the status of the retinoblastoma (RB) protein by immunoblotting analysis using antibodies raised against the TrpE-RB fusion protein. One of 16 cell lines examined, the T-cell acute lymphoblastic leukemia (ALL) line HSB-2, lacked the 110-Kd RB protein. Southern blot analysis of genomic DNA extracted from HSB-2 cells showed a large homozygous deletion of the RB gene, stretching from exon 18 beyond exon 27. Northern blot analysis showed multiple, abnormal RB transcripts in HSB-2. A truncated protein (72 Kd) was detected with 35S-methionine labeling but not with 32P-orthophosphate labeling of the HSB-2 cells. The genomic deletion of greater than 85 kb DNA at the RB locus (13q14) was not detectable in the karyotype of the HSB-2 cells. Among the 16 human leukemia cell lines examined for the status of the RB gene, only one, the HSB-2 line, showed an abnormal RB protein. Further study of primary leukemia and lymphoma samples appears to be warranted.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2404525

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  9 in total

Review 1.  Shielding the messenger (RNA): microRNA-based anticancer therapies.

Authors:  Elena Sotillo; Andrei Thomas-Tikhonenko
Journal:  Pharmacol Ther       Date:  2011-04-14       Impact factor: 12.310

2.  The tumorigenic potential and cell growth characteristics of p53-deficient cells are equivalent in the presence or absence of Mdm2.

Authors:  S N Jones; A T Sands; A R Hancock; H Vogel; L A Donehower; S P Linke; G M Wahl; A Bradley
Journal:  Proc Natl Acad Sci U S A       Date:  1996-11-26       Impact factor: 11.205

3.  Frequent mutations in the p53 tumor suppressor gene in human leukemia T-cell lines.

Authors:  J Cheng; M Haas
Journal:  Mol Cell Biol       Date:  1990-10       Impact factor: 4.272

Review 4.  Genetics of cancer predisposition and progression.

Authors:  K Schwechheimer; W K Cavenee
Journal:  Clin Investig       Date:  1993-06

5.  Expression of the retinoblastoma protein is regulated in normal human tissues.

Authors:  C Cordon-Cardo; V M Richon
Journal:  Am J Pathol       Date:  1994-03       Impact factor: 4.307

6.  Purification and characterization of human papillomavirus type 16 E7 protein with preferential binding capacity to the underphosphorylated form of retinoblastoma gene product.

Authors:  Y Imai; Y Matsushima; T Sugimura; M Terada
Journal:  J Virol       Date:  1991-09       Impact factor: 5.103

7.  Two distinct and frequently mutated regions of retinoblastoma protein are required for binding to SV40 T antigen.

Authors:  S Huang; N P Wang; B Y Tseng; W H Lee; E H Lee
Journal:  EMBO J       Date:  1990-06       Impact factor: 11.598

8.  Distinct sub-populations of the retinoblastoma protein show a distinct pattern of phosphorylation.

Authors:  S Mittnacht; J A Lees; D Desai; E Harlow; D O Morgan; R A Weinberg
Journal:  EMBO J       Date:  1994-01-01       Impact factor: 11.598

9.  Chromosomal translocations joining LCK and TCRB loci in human T cell leukemia.

Authors:  B Tycko; S D Smith; J Sklar
Journal:  J Exp Med       Date:  1991-10-01       Impact factor: 14.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.